Close Menu

NEW YORK – During the American Association for Clinical Chemistry annual meeting last month, panelists from industry organizations including AdvaMedDx and the American Clinical Laboratory Association (ACLA) highlighted the impact of reimbursement cuts driven by the Protecting Access to Medicare Act (PAMA) on point-of-care (POC) testing.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.


As worldwide COVID-19 cases continue to rise, there is a significant need to increase testing and population surveillance capacity.

Sponsored by

This webinar will present a case study from in vitro diagnostics developer SpeeDx on its experience building a complete sample-to-result workflow — encompassing instrumentation and data analysis software — for its qPCR-based ResistancePlus MG Mycoplasma genitalium assay.